Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01452607 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
A Phase 1 study, sponsored by Sound Pharmaceuticals, Incorporated.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT01452607 is a Phase 1 study that has completed, run by Sound Pharmaceuticals, Incorporated. The registered enrollment target is 32 participants.
The verdict
NCT01452607, a Phase 1 study, has completed, sponsored by Sound Pharmaceuticals, Incorporated.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
A study to determine the safety, tolerability, and pharmacokinetics of SPI-1005 capsules in healthy adults.
Interventions
- DRUG Placebo
- DRUG SPI-1005
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2006-05 |
| Est. Completion | 2006-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01452607
The ClinicalTrials.gov registry entry for NCT01452607 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sound Pharmaceuticals, Incorporated, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01452607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01452607 about?
NCT01452607 is a clinical study titled "Study to Evaluate the Safety and Pharmacokinetics of SPI-1005". A study to determine the safety, tolerability, and pharmacokinetics of SPI-1005 capsules in healthy adults.
What is the current status of trial NCT01452607?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2006-05. Estimated completion is 2006-08.
What interventions are being tested in trial NCT01452607?
The interventions under investigation include: Placebo (DRUG), SPI-1005 (DRUG).
Who is sponsoring clinical trial NCT01452607?
This trial is sponsored by Sound Pharmaceuticals, Incorporated, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.